HR 1285 113th Congress House Crime and Law Enforcement Drug trafficking and controlled substances Health care coverage and access Long-term, rehabilitative, and terminal care Prescription drugs Rural conditions and development

To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.

Introduced: March 20, 2013 Introduced by: Buchanan, Vern Republican · Florida See on congress.gov

Everywhere this bill has been 4 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Apr 15, 2013

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.

Mar 22, 2013

Referred to the Subcommittee on Health.

Mar 20, 2013

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Mar 20, 2013

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance.

Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone compound products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date enactment of this Act.

Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.

What's happening now April 15, 2013

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.

Related & companion bills 1

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 4

Crime and Federal Government Surveillance Subcommittee
House of Representatives · subcommittee of Judiciary Committee
Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee
Judiciary Committee
House of Representatives

Cosponsors 36

Lipinski, Daniel

· May 14, 2013

Schakowsky, Janice D.

Illinois · May 14, 2013